Status:
UNKNOWN
Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma Cells
Lead Sponsor:
Mackay Memorial Hospital
Conditions:
Carcinoma, Hepatocellular
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
Hepatoma ranks the first on the cancer mortality list in Taiwan, and there are currently no other effective treatment options for advanced HCC. Therefore, alternative medical intervention is needed to...
Detailed Description
Hepatoma ranks the first two of the cancer mortality list in Taiwan, and there are currently no effective treatment options for advanced HCC. Therefore, novel medical intervention is needed to improve...
Eligibility Criteria
Inclusion
- Hepatoma patients indicated for operation
Exclusion
- With major systemic disease including other cancer or coagulopathy
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
End Date :
June 1 2006
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00327496
Start Date
June 1 2005
End Date
June 1 2006
Last Update
May 18 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.